Skip to main content
Eduardo Leonardo, MD, Psychiatry, New York, NY, New York-Presbyterian Hospital

EduardoDavidLeonardoMD

Psychiatry New York, NY

Psychopharmacology

Eduardo David Leonardo M.D., Ph.D.

Dr. Leonardo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Leonardo's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric Institute
    New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 1999 - 2003
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1999
  • University of California, San Francisco
    University of California, San FranciscoPh.D., Cell Biology, 1990 - 1997
  • Yale University
    Yale UniversityB.S., Molecular Biophysics and Biochemistry, Cum Laude, 1986 - 1990

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2020 - 2025
  • NY State Medical License
    NY State Medical License 2000 - 2025
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Laughlin Fellow American College of Psychiatrists, 2003
  • Alumni Award for Excellence in Psychiatry 2003

Publications & Presentations

PubMed

Journal Articles

  • Targeting Kruppel-like Factor 9 in Excitatory Neurons Protects against Chronic Stress-induced Impairments in Dendritic Spines and Fear Responses  
    Besnard, A., Langberg, T., Levinson, S., Chu, D., Vicidomini, C., Scobie, K.N., Dwork, A.J., Arango, V., Rosoklija, G.B., Mann, J.J., Hen, R., Leonardo, E.D., Boldrini..., Cell Reports, 1/12/2018
  • Ablation of proliferating neural stem cells during early life is sufficient to reduce adult hippocampal neurogenesis  
    Youssef, M., Krish, V.S., Kirshenbaum, G.S. Atsak, P., Lass, T.J., Lieberman, S.R., Leonardo, E.D., Dranovsky, A., Hippocampus, 1/1/2018
  • Serotonin inputs to the dorsal BNST modulate anxiety in a 5-HT1A receptor dependent manner  
    Garcia-Garcia, A.L., Canetta, S., Stujenske, J.M., Burghardt, N.S., Ansorge, M.S., Dranovsky, A., Leonardo, E.D., Molecular Psychiatry, 1/1/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Serotonin signaling through Prefrontal Cortex 5-HT1A receptors during adolescence can bi-directionally determine baseline Mood-related behaviours 
    Cork, Ireland - 1/1/2018
  • Lifelong Mood and Anxiety Setpoints 
    1/1/2017
  • Setting Lifelong Mood and Anxiety Setpoints: Insights from Studies in Mice 
    1/1/2014
  • Join now to see all

Other

  • Genetics of Affective and Anxiety Disorders 
    Leonardo, E. D., and Hen, R., Annual Review of Psychology
    1/1/2006
  • Molecular Studies of Axonal Chemorepulsion 
    Leonardo ED, University of California
    1/1/1997
  • Guidance of Developing Axons by Netrin-1 and its Receptors 
    Leonardo, E.D., Hinck, L., Masu, M., Keino-Masu, K., Fazeli, A., Stoeckli, E.T., Ackerman, S.A., Weinberg, R.A., and Tessier-Lavigne, M., Cold Spring Harbor Symposia on Quantitative Biology
    1/1/1997

Grant Support

  • A LATE Sensitive Period For The Development Of Anxiety DisordersNational Institute Of Mental Health2010–2012
  • Hippocampal Neurogenesis: Mechanisms Of Antidepressant ActionNational Institute Of Mental Health2006–2010

Hospital Affiliations